- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.11.24 | Novartis raises mid-term sales outlook on pipeline promise | ||
| 21.11.24 | Eisai debuts biliary tract cancer drug in Japan | ||
| 21.11.24 | 23andMe stock sell-off adds to its woes | ||
| 21.11.24 | Pfizer elevates Chris Boshoff to top R&D role | ||
| 20.11.24 | Sage wilts as Huntington's prospect flunks trial | ||
| 20.11.24 | Pfizer bags EU okay for haemophilia drug Hympavzi | ||
| 20.11.24 | Trump picks celebrity doc Mehmet Oz to lead Medicare | ||
| 20.11.24 | NICE blames companies for breakdown in Enhertu talks | ||
| 20.11.24 | MSD says subcutaneous Keytruda matches IV form | ||
| 19.11.24 | NIH algorithm matches patients to clinical trials | ||
| 19.11.24 | GSK drug raises hopes for patients with PBC itch | ||
| 19.11.24 | J&J plots filings after psoriasis drug clears phase 3 test | ||
| 19.11.24 | FDA says no to Astellas' geographic atrophy drug | ||
| 19.11.24 | Grifols linked to €7bn takeover offer from Brookfield | ||
| 18.11.24 | Neurogene falls again on Rett gene therapy side effects | ||
| 18.11.24 | AI could 'cut ECG result wait times and speed up treatment' | ||
| 18.11.24 | AbbVie bags EU nod for key drug from ImmunoGen takeover | ||
| 18.11.24 | Tirzepatide gets a big win in obesity-related heart failure | ||
| 18.11.24 | Syndax gets FDA okay for first-in-class leukaemia drug | ||
| 15.11.24 | Trump pick of RFK for top US health job astounds critics | ||
| 14.11.24 | MSD joins PD-1/VEGF push in cancer with LaNova deal | ||
| 14.11.24 | Syncona aims Slingshot at biotech's 'translational gap' | ||
| 14.11.24 | GSK hails survival data with revived myeloma drug Blenrep | ||
| 14.11.24 | Metsera gets $215m for obesity trials, and other financings | ||
| 14.11.24 | PTC gets FDA okay for first brain-delivered gene therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
